This is akin to the supplement industry, says Michelle Davey, founder and CEO of telehealth company Wheel
[3] [4] It belongs to a novel class of medicines known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists
What it does in the MicroInfuser context: dermal hydration (low-MW), volumetric plumping in upper dermis (mid-MW), barrier-protective film in the post-procedure window (high-MW), and CD44 receptor engagement on fibroblasts
Cell Metab 36(6):13021319 e12 Scott Butsch W, Sulo S, Chang AT, Kim JA, Kerr KW, Williams DR et al (2025) Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study
There's a scientific explanation of what's happening
Gives moisturization to the skin